How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Extracellular Pre-coated Plates Market
- By Plate Type: 96-well plates, 24-well plates, 12-well plates, 6-well plates, 384-well plates
- By Coating Material: Collagen, Fibronectin, Laminin, Poly-D-Lysine, Gelatin
- By End-user: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Clinical Laboratories
- By Application: Cell Culture and Expansion, Drug Discovery and Development, Tissue Engineering, Stem Cell Research, Toxicology Testing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - 96-well plates leads By Plate Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Extracellular Pre-coated Plates Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Corning Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →SPL Life Sciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nunc (part of Thermo Fisher Scientific)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BD Biosciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →CELLCO Biotech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Eppendorf AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sartorius AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →AGC Biologics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Biocoat (part of Corning)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →MatTek Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →ibidi GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →CELLnTEC Advanced Cell Systems AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →ScienCell Research Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- 96-well plates51.7
- 24-well plates8.7
- 12-well plates14.6
- 6-well plates14.9
- 384-well plates10.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Corning Incorporated21.4
- Thermo Fisher Scientific Inc.11.6
- Greiner Bio-One International GmbH8.3
- SPL Life Sciences14.0
- Nunc (part of Thermo Fisher Scientific)5.9
- BD Biosciences10.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.3
- Europe21.5
- Asia Pacific20.8
- Latin America14.4
- Middle East and Africa10.1
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Corning Incorporated | 94 | 92 | 83 | 91 | 86 | 84 | 88 |
| Thermo Fisher Scientific Inc. | 71 | 83 | 79 | 69 | 72 | 88 | 77 |
| Greiner Bio-One International GmbH | 76 | 88 | 86 | 80 | 72 | 63 | 78 |
| SPL Life Sciences | 75 | 57 | 65 | 59 | 57 | 74 | 65 |
| Nunc (part of Thermo Fisher Scientific) | 59 | 52 | 69 | 67 | 61 | 65 | 62 |
| BD Biosciences | 61 | 59 | 57 | 46 | 62 | 60 | 58 |
| CELLCO Biotech | 47 | 63 | 50 | 57 | 51 | 65 | 56 |
| Eppendorf AG | 51 | 42 | 40 | 60 | 38 | 60 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Corning Incorporated
- Thermo Fisher Scientific Inc.
- Greiner Bio-One International GmbH
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Corning Incorporated | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Thermo Fisher Scientific Inc. | − | ◐ | ✓ | ✓ | ◐ | ◐ |
| Greiner Bio-One International GmbH | ✓ | ◐ | ✓ | ✓ | ◐ | − |
| SPL Life Sciences | ✓ | ◐ | ◐ | − | ◐ | ◐ |
| Nunc (part of Thermo Fisher Scientific) | ◐ | − | ◐ | ◐ | − | ◐ |
| BD Biosciences | ◐ | ◐ | − | − | − | − |
| CELLCO Biotech | − | ◐ | − | − | − | ◐ |
| Eppendorf AG | ◐ | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger1
Strong scale, closing on the leaders.
Contender3
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Plate Type in North America, then scale across Extracellular Pre-coated Plates Market — a $508M beachhead inside a $7.67B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →96-well plates
Best fit — highest urgency & budget in Plate Type.
24-well plates
Strong fit — clear ROI and a fast path to value.
12-well plates
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Plate Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Coating Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-user
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Plate Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Extracellular Pre-coated Plates Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Extracellular Pre-coated Plates Market is a durable-growth opportunity — $2.46B by 2033, compounding at 9.1%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.1% CAGR
Demand compounds through 2033, outpacing GDP across Plate Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Plate Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Coating Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Extracellular Pre-coated Plates Market — a $2.85B market by 2033. Plan: grow share from 6.5% to 11.1%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.5% | 11.1% | Ahead |
| Revenue | $186M | $317M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 37.4% | 42.4% | Ahead |
| Customer retention | 90.7% | 95.6% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Plate Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Coating Material capability
A defensible second engine — invest in Coating Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Plate Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Coating Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $32M capacity & capability investment
- Greenlight bolt-on M&A in Coating Material
- Authorise North America expansion plan
- Fund R&D program for Plate Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Extracellular Pre-coated Plates Market conversation — a $2.55B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Plate Type
Goal Grow share in Plate Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Extracellular Pre-coated Plates Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Extracellular Pre-coated Plates Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Extracellular Matrix Protein Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportExtracellular Matrix Patch Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportExtracellular Matrix Patches Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportExternal VNS Device Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportExternal Vibrating Expectorant Machine Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportExternal Ventricular Drain Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportExternal Ventricular Drainage System Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportExternal Ventricular Drainage Set Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportExternal Ventricular Drainage Drains Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportExternal Urine Management Products Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportExternal Urine Management Devices Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportExternal Urine Collection Device Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy